Item 5.02 Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers.On August 8 2024 the Company announced that Adam S. Taich will be joining the Company as its Chief Financial Officer effective August 12 2024 replacing Justin J. McAnear who on August 6 2024 notified the Company of his intention to resign and who will continue to provide transition services as an employee of the Company through August 30 2024. Effective as of August 12 2024 Mr. Taich will serve as the Companys Chief Financial Officer Treasurer principal financial officer and principal accounting officer. Mr. Taich 49 previously served as Chief Strategy Officer of Standard BioTools Inc. from January 2024 to July 2024. He previously served as interim Chief Executive Officer of SomaLogic Inc. a proteomics company from March 2023 until SomaLogics acquisition by Standard BioTools in January 2024. Mr. Taich served as SomaLogics Chief Business Officer from November 2021 to March 2023 as well as SomaLogics Executive Vice President of Life Sciences from April 2022 to March 2023. Prior to joining SomaLogic Mr. Taich spent 19 years at ThermoFisher Scientific a global supplier of scientific instrumentation reagents and software services in various roles including as Vice President &amp General ManagerMolecular Biology from February 2020 to June 2021 Vice PresidentStrategy and Business Development from April 2018 to February 2020 Vice President &amp General ManagerProtein and Cell Analysis from October 2016 to April 2018 Vice President &amp General ManagerGlobal Services and Support from November 2013 to October 2016 and in various other roles from 2004 to 2013. Mr. Taich holds a B.A. in Political Science and Russian from Miami University in Oxford Ohio.In connection with his employment Mr. Taich signed an offer letter with the Company on August 7 2024 (the Offer Letter) which provides that Mr. Taich will receive an annual base salary of $500000 and a target annual bonus equal to 60% of his eligible base salary. The Offer Letter also provides that subject to approval by the Companys Board of Directors Mr. Taich will receive a grant of restricted stock units under the Companys 2019 Omnibus Incentive Plan having a target value equal to $4500000 which will vest as to one fourth of such grant on August 21 2025 and thereafter in equal quarterly installments for the following three years subject to his continued service through each vesting date. Additionally Mr. Taich shall also be eligible to participate in employee benefit plans and programs that are generally available to other senior executives of the Company located in the United States including the Companys Change in Control Severance Policy (the Severance Policy) discussed in the Companys definitive proxy statement on Schedule 14A for its 2024 annual meeting of stockholders filed with the Securities and Exchange Commission (SEC) on April 26 2024. Mr. Taich would be entitled to a lump sum severance payment equal to six (6) months of his base salary in effect at the time of his termination subject to his execution and non-revocation of a release of claims if he was terminated by us without Cause (as defined in the Severance Policy) prior to August 21 2025.Mr. Taich in connection with his employment has entered into the Companys standard indemnification agreement the form of which has been filed as Exhibit 10.17 to the Companys Amendment No. 1 to Registration Statement on Form S-1 filed with the SEC on September 3 2019 and the Companys standard At-Will Employment Confidential Information Invention Assignment and Arbitration Agreement which has been filed as Exhibit 10.16 to the Companys Registration Statement on Form S-1 filed with the SEC on August 19 2019.There are no arrangements or understandings with any other person pursuant to which Mr. Taich was appointed as the Companys Chief Financial Officer and there are no family relationships between Mr. Taich and any director or executive officer of the Company. Additionally there are no transactions between Mr. Taich and the Company that would be required to be reported under Item 404(a) of Regulation S-K.